Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term. Read why MEDP stock is a Strong Buy.

X-Elio will supply 245GWh of clean energy annually to four pharmaceutical companies through its Lorca Solar project.

ELIO, Thermo Fisher Scientific is closer to its goal of powering its European sites with 100% renewable energy ...

This marks the second round of layoffs at the company in less than three months. In November, the company cut 160 jobs across several Massachusetts sites, including the closure of its Lexington ...

Thermo Fisher Scientific Inc. announced the launch of the international CorEvitas Adolescent Alopecia Areata (AA) Registry.

Let's sort the S&P 500 healthcare sector again to show the 10 stocks with the highest percentages of "buy" or equivalent ratings. Only five companies are on both this list and the above growth list: ...